Skip to content

Michael Jeltsch

  • Dr.
  • Group leader & Academy Research Fellow
  • Helsingin yliopisto - University of Helsinki
  • 36h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 11512CitationsNumber of citations received by Michael's publications. Updated daily.


2013 Group leader in the Translational Cancer Biology Program, University of Helsinki, Finland 2011 Habilitation (Proteinchemie), University of Helsinki, Finland 2002 PhD (Biochemistry), University of Helsinki, Finland 1997 MSc (Biochemistry), University of Helsinki, Finland 1992 BSc ("Vordiplom", Biochemie/Molekularbiologie), University of Hamburg, Germany 1989 Allgemeine Hochschulreife, Gymnasium An der Stenner, Iserlohn, Germany July 28, 1969 Born in Hemer/NW, Germany

Professional experience

Group leader & Academy Research Fellow

Helsingin yliopisto - University of Helsinki

September 2013 - Present

Postdoctoral Fellow

Wihuri Research Institute

January 2013 - August 2013(7 months)

graduate student, postgraduate student, postdoc

Molecular/Cancer Biology Lab, University of Helsinki

May 1996 - August 2013(17 years)


Circadian Technologies via Vegenics Ltd. via Licentia Ltd.

February 2007 - December 2011(5 years)


Lymphatix Ltd. (now Ark Therapeutics) via Licentia Ltd.

April 2006 - January 2007(9 months)

Studentische Hilfskraft

Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg

August 1993 - July 1994(a year)



University of Helsinki

June 1997 - December 2002(6 years)


University of Helsinki

September 1994 - May 1997(3 years)


University of Hamburg

September 1990 - August 1994(4 years)

Co-authors (257)